pneumococcal polyvalent vaccine

BIOLOGICAL7 trials

Sponsors

University of Maryland, Baltimore, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, University of Maryland Greenebaum Cancer Center, Mayo Clinic, National Cancer Institute (NCI)

Conditions

Adult Diffuse Mixed Cell LymphomaAdult Diffuse Small Cleaved Cell LymphomaAdult Grade III Lymphomatoid GranulomatosisAdult Immunoblastic Large Cell LymphomaAdult Lymphoblastic LymphomaAnn Arbor Stage I Small Lymphocytic LymphomaAnn Arbor Stage II Small Lymphocytic LymphomaChronic Lymphocytic Leukemia

Early Phase 1

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

CompletedNCT01239875

Mayo ClinicAdult Diffuse Mixed Cell Lymphoma, Adult Diffuse Small Cleaved Cell Lymphoma, Adult Grade III Lymphomatoid Granulomatosis +13

Start: 2010-11-30End: 2019-07-17Updated: 2020-01-14

Phase 1

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

CompletedNCT00046852

University of Maryland, BaltimoreInfection, Multiple Myeloma and Plasma Cell Neoplasm

Start: 2001-12-31End: 2008-02-29Updated: 2019-11-04

Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma

CompletedNCT00499577

University of Maryland Greenebaum Cancer CenterMultiple Myeloma and Plasma Cell Neoplasm

Start: 2006-12-31Target: 56Updated: 2014-01-10

Phase 2

Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

CompletedNCT00445484

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMultiple Myeloma and Plasma Cell Neoplasm

Start: 2007-01-31End: 2010-09-30Updated: 2015-08-24

Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Active, not recruitingNCT01351896

National Cancer Institute (NCI)Ann Arbor Stage II Small Lymphocytic Lymphoma, Ann Arbor Stage I Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia +6

Start: 2011-11-02End: 2026-05-06Updated: 2025-11-20

Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

RecruitingNCT05183854

University of UtahChronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Start: 2022-01-31End: 2028-06-01Target: 60Updated: 2026-02-17

Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia

RecruitingNCT05417165

Seema BhatChronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Start: 2023-09-29End: 2026-10-31Target: 80Updated: 2026-01-07

Related Papers

Extended Follow up of a Phase 2 Study of Early Intervention with Lenalidomide in Patients with High-Risk Chronic Lymphocytic Leukemia

Blood2023-11-021 citations

Clinical Predictors of T Cell Fitness for CAR T Cell Manufacturing and Efficacy in Multiple Myeloma

Blood2018-11-2936 citations

Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress

Journal for ImmunoTherapy of Cancer2014-11-06

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.

2010-10-28117 citations

Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.

2010-09-2331 citations